Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy

Objectives: To assess the predictive and prognostic value of changes in longitudinal neutrophile-to-lymphocyte (NLR) ratios in men receiving taxane-based chemotherapy for metastatic prostate cancer (PC). Methods: Retrospective, unicentric cohort study of patients treated with either docetaxel for me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Neuberger, Manuel (VerfasserIn) , Weiß, Christel (VerfasserIn) , Goly, Nora (VerfasserIn) , Skladny, Janina (VerfasserIn) , Nitschke, Katja (VerfasserIn) , Wessels, Frederik (VerfasserIn) , Kowalewski, Karl-Friedrich (VerfasserIn) , Waldbillig, Frank (VerfasserIn) , Hartung, Friedrich (VerfasserIn) , Nientiedt, Malin (VerfasserIn) , Egen, Luisa (VerfasserIn) , Herrmann, Jonas (VerfasserIn) , Jarczyk, Jonas (VerfasserIn) , Walach, Margarete (VerfasserIn) , Kriegmair, Maximilian (VerfasserIn) , Westhoff, Niklas Christian (VerfasserIn) , Worst, Thomas (VerfasserIn) , Nuhn, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 December 2022
In: Discover oncology
Year: 2022, Jahrgang: 13, Pages: 1-12
ISSN:2730-6011
DOI:10.1007/s12672-022-00603-0
Online-Zugang:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1007/s12672-022-00603-0
Verlag, kostenfrei, Volltext: https://link.springer.com.ezproxy.medma.uni-heidelberg.de/article/10.1007/s12672-022-00603-0
Volltext
Verfasserangaben:Manuel Neuberger, Christel Weiß, Nora Goly, Janina Skladny, Katja Nitschke, Frederik Wessels, Karl F. Kowalewski, Frank Waldbillig, Friedrich Hartung, Malin Nientiedt, Luisa Egen, Jonas Herrmann, Jonas Jarczyk, Margarete Teresa Walach, Maximilian C. Kriegmair, Niklas Westhoff, Thomas S. Worst, Philipp Nuhn

MARC

LEADER 00000caa a2200000 c 4500
001 1839048018
003 DE-627
005 20251110164354.0
007 cr uuu---uuuuu
008 230313s2022 xx |||||o 00| ||eng c
024 7 |a 10.1007/s12672-022-00603-0  |2 doi 
035 |a (DE-627)1839048018 
035 |a (DE-599)KXP1839048018 
035 |a (OCoLC)1389534332 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
084 |a 33  |2 sdnb 
100 1 |a Neuberger, Manuel  |e VerfasserIn  |0 (DE-588)118332331X  |0 (DE-627)1663137250  |4 aut 
245 1 0 |a Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy  |c Manuel Neuberger, Christel Weiß, Nora Goly, Janina Skladny, Katja Nitschke, Frederik Wessels, Karl F. Kowalewski, Frank Waldbillig, Friedrich Hartung, Malin Nientiedt, Luisa Egen, Jonas Herrmann, Jonas Jarczyk, Margarete Teresa Walach, Maximilian C. Kriegmair, Niklas Westhoff, Thomas S. Worst, Philipp Nuhn 
264 1 |c 15 December 2022 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 15 December 2022 
500 |a Gesehen am 13.03.2023 
520 |a Objectives: To assess the predictive and prognostic value of changes in longitudinal neutrophile-to-lymphocyte (NLR) ratios in men receiving taxane-based chemotherapy for metastatic prostate cancer (PC). Methods: Retrospective, unicentric cohort study of patients treated with either docetaxel for metastatic hormone-sensitive PC (mHSPC) or docetaxel or cabazitaxel for metastatic castration-refractory PC (mCRPC) at a tertiary referral hospital between 2010 and 2019. NLR ratios were calculated for each cycle. Next, slopes over the first three (NLR3) and over six cycles (NLR6) were calculated and analysed for biochemical/radiologic response and survival. Results: A total of 36 mHSPC (docetaxel), 118 mCRPC (docetaxel) and 38 mCRPC (cabazitaxel) patients were included. NLR3 was significantly associated with 1-year-survival, radiographic and biochemical response in mCRPC (docetaxel) in uni- and multivariable analyses. In mCRP (docetaxel), positive NLR3s were associated with favourable 1-year-survival. Conclusion: This study demonstrated NLR3 as a prognostic marker in men receiving docetaxel for mCRPC. NLR3 might be a clinical tool to reflect the individual’s response to taxane-based chemotherapy. Thereby, NLR3 could complement existing biomarkers and help to early identify treatment failure before complications arise. Further prospective and multicentric studies are needed to extend and confirm the presented results. 
650 4 |a Biomarkers 
650 4 |a Cabazitaxel 
650 4 |a Docetaxel 
650 4 |a Metastatic castration-resistant prostate cancer (mCRPC) 
650 4 |a Metastatic hormone-sensitive prostate cancer (mHSPC) 
650 4 |a Prognosis 
650 4 |a Treatment outcome 
700 1 |a Weiß, Christel  |d 1958-  |e VerfasserIn  |0 (DE-588)123287707  |0 (DE-627)082463417  |0 (DE-576)168356104  |4 aut 
700 1 |a Goly, Nora  |d 1992-  |e VerfasserIn  |0 (DE-588)1324375639  |0 (DE-627)1884208622  |4 aut 
700 1 |a Skladny, Janina  |d 1997-  |e VerfasserIn  |0 (DE-588)1324375280  |0 (DE-627)1884208363  |4 aut 
700 1 |a Nitschke, Katja  |d 1984-  |e VerfasserIn  |0 (DE-588)1075770823  |0 (DE-627)833830651  |0 (DE-576)444648046  |4 aut 
700 1 |a Wessels, Frederik  |d 1990-  |e VerfasserIn  |0 (DE-588)1183323255  |0 (DE-627)1663137226  |4 aut 
700 1 |a Kowalewski, Karl-Friedrich  |d 1989-  |e VerfasserIn  |0 (DE-588)1100724192  |0 (DE-627)859518825  |0 (DE-576)469770740  |4 aut 
700 1 |a Waldbillig, Frank  |d 1988-  |e VerfasserIn  |0 (DE-588)1142198081  |0 (DE-627)1001323572  |0 (DE-576)494739932  |4 aut 
700 1 |a Hartung, Friedrich  |d 1993-  |e VerfasserIn  |0 (DE-588)1223629066  |0 (DE-627)1743101791  |4 aut 
700 1 |a Nientiedt, Malin  |d 1991-  |e VerfasserIn  |0 (DE-588)114835476X  |0 (DE-627)1008678988  |0 (DE-576)496269860  |4 aut 
700 1 |a Egen, Luisa  |d 1993-  |e VerfasserIn  |0 (DE-588)1229651535  |0 (DE-627)1751720217  |4 aut 
700 1 |a Herrmann, Jonas  |d 1986-  |e VerfasserIn  |0 (DE-588)1144989396  |0 (DE-627)1005160198  |0 (DE-576)495576808  |4 aut 
700 1 |a Jarczyk, Jonas  |d 1983-  |e VerfasserIn  |0 (DE-588)1103057111  |0 (DE-627)860675580  |0 (DE-576)470468602  |4 aut 
700 1 |a Walach, Margarete  |d 1988-  |e VerfasserIn  |0 (DE-588)1143876407  |0 (DE-627)1003440851  |0 (DE-576)495204609  |4 aut 
700 1 |a Kriegmair, Maximilian  |d 1987-  |e VerfasserIn  |0 (DE-588)1049742745  |0 (DE-627)782573347  |0 (DE-576)403726840  |4 aut 
700 1 |a Westhoff, Niklas Christian  |d 1988-  |e VerfasserIn  |0 (DE-588)107322306X  |0 (DE-627)828672628  |0 (DE-576)434741752  |4 aut 
700 1 |a Worst, Thomas  |d 1985-  |e VerfasserIn  |0 (DE-588)1028335679  |0 (DE-627)73058500X  |0 (DE-576)375827501  |4 aut 
700 1 |a Nuhn, Philipp  |d 1981-  |e VerfasserIn  |0 (DE-588)136112951  |0 (DE-627)694090808  |0 (DE-576)30083909X  |4 aut 
773 0 8 |i Enthalten in  |t Discover oncology  |d [New York] : Springer, 2021  |g 13(2022), Artikel-ID 140, Seite 1-12  |h Online-Ressource  |w (DE-627)1753566347  |w (DE-600)3059869-2  |x 2730-6011  |7 nnas  |a Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy 
773 1 8 |g volume:13  |g year:2022  |g elocationid:140  |g pages:1-12  |g extent:12  |a Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy 
856 4 0 |u https://doi.org/10.1007/s12672-022-00603-0  |x Resolving-System  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://link.springer.com.ezproxy.medma.uni-heidelberg.de/article/10.1007/s12672-022-00603-0  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251110 
992 |a 20230313 
993 |a Article 
993 |a Article 
994 |a 2022 
994 |a 2022 
998 |g 136112951  |a Nuhn, Philipp  |m 136112951:Nuhn, Philipp  |d 60000  |d 63100  |e 60000PN136112951  |e 63100PN136112951  |k 0/60000/  |k 1/60000/63100/  |p 18  |y j 
998 |g 1028335679  |a Worst, Thomas  |m 1028335679:Worst, Thomas  |d 60000  |d 63100  |e 60000PW1028335679  |e 63100PW1028335679  |k 0/60000/  |k 1/60000/63100/  |p 17 
998 |g 107322306X  |a Westhoff, Niklas Christian  |m 107322306X:Westhoff, Niklas Christian  |d 60000  |d 63100  |e 60000PW107322306X  |e 63100PW107322306X  |k 0/60000/  |k 1/60000/63100/  |p 16 
998 |g 1049742745  |a Kriegmair, Maximilian  |m 1049742745:Kriegmair, Maximilian  |d 60000  |d 63100  |e 60000PK1049742745  |e 63100PK1049742745  |k 0/60000/  |k 1/60000/63100/  |p 15 
998 |g 1143876407  |a Walach, Margarete  |m 1143876407:Walach, Margarete  |d 60000  |d 63100  |e 60000PW1143876407  |e 63100PW1143876407  |k 0/60000/  |k 1/60000/63100/  |p 14 
998 |g 1103057111  |a Jarczyk, Jonas  |m 1103057111:Jarczyk, Jonas  |d 60000  |d 63100  |e 60000PJ1103057111  |e 63100PJ1103057111  |k 0/60000/  |k 1/60000/63100/  |p 13 
998 |g 1144989396  |a Herrmann, Jonas  |m 1144989396:Herrmann, Jonas  |d 60000  |e 60000PH1144989396  |k 0/60000/  |p 12 
998 |g 1229651535  |a Egen, Luisa  |m 1229651535:Egen, Luisa  |d 60000  |d 63100  |e 60000PE1229651535  |e 63100PE1229651535  |k 0/60000/  |k 1/60000/63100/  |p 11 
998 |g 114835476X  |a Nientiedt, Malin  |m 114835476X:Nientiedt, Malin  |d 60000  |d 63100  |e 60000PN114835476X  |e 63100PN114835476X  |k 0/60000/  |k 1/60000/63100/  |p 10 
998 |g 1223629066  |a Hartung, Friedrich  |m 1223629066:Hartung, Friedrich  |d 60000  |d 63100  |e 60000PH1223629066  |e 63100PH1223629066  |k 0/60000/  |k 1/60000/63100/  |p 9 
998 |g 1142198081  |a Waldbillig, Frank  |m 1142198081:Waldbillig, Frank  |d 60000  |d 63100  |e 60000PW1142198081  |e 63100PW1142198081  |k 0/60000/  |k 1/60000/63100/  |p 8 
998 |g 1100724192  |a Kowalewski, Karl-Friedrich  |m 1100724192:Kowalewski, Karl-Friedrich  |d 60000  |d 63100  |e 60000PK1100724192  |e 63100PK1100724192  |k 0/60000/  |k 1/60000/63100/  |p 7 
998 |g 1183323255  |a Wessels, Frederik  |m 1183323255:Wessels, Frederik  |d 60000  |d 63100  |e 60000PW1183323255  |e 63100PW1183323255  |k 0/60000/  |k 1/60000/63100/  |p 6 
998 |g 1075770823  |a Nitschke, Katja  |m 1075770823:Nitschke, Katja  |d 60000  |d 63100  |e 60000PN1075770823  |e 63100PN1075770823  |k 0/60000/  |k 1/60000/63100/  |p 5 
998 |g 1324375280  |a Skladny, Janina  |m 1324375280:Skladny, Janina  |d 60000  |e 60000PS1324375280  |k 0/60000/  |p 4 
998 |g 1324375639  |a Goly, Nora  |m 1324375639:Goly, Nora  |d 60000  |e 60000PG1324375639  |k 0/60000/  |p 3 
998 |g 123287707  |a Weiß, Christel  |m 123287707:Weiß, Christel  |d 60000  |d 60200  |d 60250  |d 60000  |e 60000PW123287707  |e 60200PW123287707  |e 60250PW123287707  |e 60000PW123287707  |k 0/60000/  |k 1/60000/60200/  |k 2/60000/60200/60250/  |k 0/60000/  |p 2 
998 |g 118332331X  |a Neuberger, Manuel  |m 118332331X:Neuberger, Manuel  |d 60000  |d 63100  |e 60000PN118332331X  |e 63100PN118332331X  |k 0/60000/  |k 1/60000/63100/  |p 1  |x j 
999 |a KXP-PPN1839048018  |e 4801942547 
999 |a KXP-PPN1839048018  |e 4288795788 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Neuberger, Manuel","given":"Manuel","family":"Neuberger","role":"aut"},{"role":"aut","family":"Weiß","given":"Christel","display":"Weiß, Christel"},{"role":"aut","family":"Goly","display":"Goly, Nora","given":"Nora"},{"family":"Skladny","display":"Skladny, Janina","given":"Janina","role":"aut"},{"role":"aut","family":"Nitschke","given":"Katja","display":"Nitschke, Katja"},{"display":"Wessels, Frederik","given":"Frederik","family":"Wessels","role":"aut"},{"family":"Kowalewski","given":"Karl-Friedrich","display":"Kowalewski, Karl-Friedrich","role":"aut"},{"role":"aut","display":"Waldbillig, Frank","given":"Frank","family":"Waldbillig"},{"family":"Hartung","given":"Friedrich","display":"Hartung, Friedrich","role":"aut"},{"role":"aut","family":"Nientiedt","given":"Malin","display":"Nientiedt, Malin"},{"family":"Egen","given":"Luisa","display":"Egen, Luisa","role":"aut"},{"family":"Herrmann","display":"Herrmann, Jonas","given":"Jonas","role":"aut"},{"role":"aut","display":"Jarczyk, Jonas","given":"Jonas","family":"Jarczyk"},{"display":"Walach, Margarete","given":"Margarete","family":"Walach","role":"aut"},{"given":"Maximilian","display":"Kriegmair, Maximilian","family":"Kriegmair","role":"aut"},{"role":"aut","display":"Westhoff, Niklas Christian","given":"Niklas Christian","family":"Westhoff"},{"given":"Thomas","display":"Worst, Thomas","family":"Worst","role":"aut"},{"role":"aut","family":"Nuhn","given":"Philipp","display":"Nuhn, Philipp"}],"recId":"1839048018","origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"15 December 2022"}],"name":{"displayForm":["Manuel Neuberger, Christel Weiß, Nora Goly, Janina Skladny, Katja Nitschke, Frederik Wessels, Karl F. Kowalewski, Frank Waldbillig, Friedrich Hartung, Malin Nientiedt, Luisa Egen, Jonas Herrmann, Jonas Jarczyk, Margarete Teresa Walach, Maximilian C. Kriegmair, Niklas Westhoff, Thomas S. Worst, Philipp Nuhn"]},"language":["eng"],"title":[{"title":"Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy","title_sort":"Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy"}],"physDesc":[{"extent":"12 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1839048018"],"doi":["10.1007/s12672-022-00603-0"]},"relHost":[{"pubHistory":["Volume 12, issue 1 (December 2021)-"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"1753566347","disp":"Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapyDiscover oncology","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["1753566347"],"issn":["2730-6011"],"zdb":["3059869-2"]},"part":{"pages":"1-12","year":"2022","extent":"12","text":"13(2022), Artikel-ID 140, Seite 1-12","volume":"13"},"note":["Gesehen am 09.04.2021"],"origin":[{"dateIssuedDisp":"[2021]-","publisher":"Springer","publisherPlace":"[New York]"}],"title":[{"title_sort":"Discover oncology","title":"Discover oncology"}]}],"note":["Published online: 15 December 2022","Gesehen am 13.03.2023"]} 
SRT |a NEUBERGERMCHANGESINN1520